Phase I trial of 96-hour continuous infusion of dexrazoxane in patients with advanced malignancies

Merry L. Tetef, Timothy W. Synold, Warren Chow, Lucille Leong, Kim Margolin, Robert Morgan, James Raschko, Stephen Shibata, George Somlo, Yun Yen, James H. Doroshow, Susan Groshen, Kay Johnson, Heinz Josef Lenz, David Gandara

研究成果: 雜誌貢獻 › 文章 › 同行評審

26 引文 斯高帕斯（Scopus）

指紋

深入研究「Phase I trial of 96-hour continuous infusion of dexrazoxane in patients with advanced malignancies」主題。共同形成了獨特的指紋。

Pharmacology, Toxicology and Pharmaceutical Science